Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardio...

por Home, P. D., Kahn, S. E., Jones, N. P., Noronha, D., Beck-Nielsen, H., Viberti, G.
Publicado 2010

Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) stu...

por Ritz, E., Viberti, G. C., Ruilope, L. M., Rabelink, A. J., Izzo, J. L., Katayama, S., Ito, S., Mimran, A., Menne, J., Rump, L. C., Januszewicz, A., Haller, H.
Publicado 2009